Erlotinib in Advanced Non-small Cell Lung Cancer Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study

Grants

Funding Acknowledgements

Supported by F. Hoffmann-La Roche Ltd. The authors thank all the patients, investigators, and site staff, in addition to the F. Hoffmann-La Roche study team members and monitors who were involved in this study. They also thank Abdul Al Khaleeb of Gardiner-Caldwell Communications for editorial assistance; this support was funded by F. Hoffmann-La Roche.